DIAGNOSTIC VALUE OF GALECTIN-3 LEVEL IN PATIENTS WITH CHRONIC HEART FAILURE AND TYPE 2 DIABETES
Currently, a greater emphasis is placed on the search for additional biomarkers of chronic heart failure (CHF). Galectin-3, a marker of fibrosis and inflammation, has shown himself as a biomarker of CHF in many studies, but the dynamics of its levels in patients with concomitant diabetes mellitus (D...
Main Authors: | A. A. Snetkova, N. Yu. Timofeeva, V. S. Zadionchenko |
---|---|
Format: | Article |
Language: | English |
Published: |
Stolichnaya Izdatelskaya Kompaniya
2015-09-01
|
Series: | Racionalʹnaâ Farmakoterapiâ v Kardiologii |
Subjects: | |
Online Access: | https://www.rpcardio.com/jour/article/view/78 |
Similar Items
-
Cardiac rehabilitation in chronic heart failure
by: Romualdo Belardinelli
Published: (2016-11-01) -
Evaluation of the relationship of immuno-inflammatory process with dyslipidemia and myocardial morphofunctional parameters in patients with chronic heart failure on the background of rheumatoid arthritis
by: A. S. Ankudinov, et al.
Published: (2020-09-01) -
AFFECTIVE DISORDERS IN PATIENTS WITH DIASTOLIC CHRONIC HEART FAILURE
by: V. A. Lusov, et al.
Published: (2010-06-01) -
The relationship of diurnal variability and level of glycemia with structural and functional parameters of heart in patients with chronic heart failure and diabetes mellitus type 2
by: Виктор Денисович Сиволап, et al.
Published: (2016-01-01) -
Pathogenetic treatment of chronic heart failure: the role of torasemide
by: N B Perepech
Published: (2015-09-01)